Human Hemorrhagic Pulmonary Leptospirosis: Pathological Findings and Pathophysiological Correlations

Carregando...
Imagem de Miniatura
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS ONE, v.8, n.8, article ID e71743, 10p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Leptospirosis is a re-emerging zoonosis with protean clinical manifestations. Recently, the importance of pulmonary hemorrhage as a lethal complication of this disease has been recognized. In the present study, five human necropsies of leptospirosis (Weil's syndrome) with extensive pulmonary manifestations were analysed, and the antibodies expressed in blood vessels and cells involved in ion and water transport were used, seeking to better understand the pathophysiology of the lung injury associated with this disease. Principal Findings: Prominent vascular damage was present in the lung microcirculation, with decreased CD34 and preserved aquaporin 1 expression. At the periphery and even inside the extensive areas of edema and intraalveolar hemorrhage, enlarged, apparently hypertrophic type I pneumocytes (PI) were detected and interpreted as a non-specific attempt of clearence of the intraalveolar fluid, in which ionic transport, particularly of sodium, plays a predominant role, as suggested by the apparently increased ENaC and aquaporin 5 expression. Connexin 43 was present in most pneumocytes, and in the cytoplasm of the more preserved endothelial cells. The number of type II pneumocytes (PII) was slightly decreased when compared to normal lungs and those of patients with septicemia from other causes, a fact that may contribute to the progressively low PI count, resulting in deficient restoration after damage to the alveolar epithelial integrity and, consequently, a poor outcome of the pulmonary edema and hemorrhage. Conclusions: Pathogenesis of lung injury in human leptospirosis was discussed, and the possibility of primary non-inflammatory vascular damage was considered, so far of undefinite etiopathogenesis, as the initial pathological manifestation of the disease.
Palavras-chave
Referências
  1. Andrade L, 2007, AM J PHYSIOL-RENAL, V292, pF586, DOI 10.1152/ajprenal.00102.2006
  2. Araujo ER, 2010, VIRCHOWS ARCH, V456, P367, DOI 10.1007/s00428-010-0894-8
  3. Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017
  4. Borok Z, 2002, AM J PHYSIOL-LUNG C, V282, pL599, DOI 10.1152/ajplung.00130.2002
  5. Clerici C, 2011, AM J PHYSIOL-LUNG C, V301, pL20, DOI 10.1152/ajplung.00126.2011
  6. Croda J, 2010, CLIN MICROBIOL INFEC, V16, P593, DOI 10.1111/j.1469-0691.2009.02916.x
  7. De Brito T, 2006, VIRCHOWS ARCH, V448, P576, DOI 10.1007/s00428-006-0163-z
  8. DEBRITO T, 1979, J PATHOL, V128, P177, DOI 10.1002/path.1711280403
  9. Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991
  10. Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029
  11. Droemann D, 2003, HISTOCHEM CELL BIOL, V119, P103, DOI 10.1007/s00418-003-0497-4
  12. Garcia MAM, 2000, EUR J CLIN MICROBIOL, V19, P471
  13. Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596
  14. Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103
  15. Luks AM, 2003, CHEST, V123, P639, DOI 10.1378/chest.123.2.639
  16. Marchiori E, 2011, LUNG, V189, P1, DOI 10.1007/s00408-010-9273-0
  17. Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
  18. Matthay MA, 2002, AM J PHYSIOL-LUNG C, V282, pL595, DOI 10.1152/ajplung.00473.2001
  19. Matthay MA, 2007, NAT MED, V13, P780, DOI 10.1038/nm0707-780
  20. McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
  21. MILLER NG, 1974, MED MICROBIOL IMMUN, V160, P269, DOI 10.1007/BF02121442
  22. Minami M, 2012, PATHOL INT, V62, P99, DOI 10.1111/j.1440-1827.2011.02756.x
  23. Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7
  24. Nicodemo AC, 1997, AM J TROP MED HYG, V56, P181
  25. Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867
  26. Olesen ETB, 2009, NEPHROL DIAL TRANSPL, V24, P2338, DOI 10.1093/ndt/gfp011
  27. Ordonez NG, 2012, ADV ANAT PATHOL, V19, P281, DOI 10.1097/PAP.0b013e3182691c2a
  28. PARK SK, 1989, AM J TROP MED HYG, V41, P345
  29. Rannels DE, 2001, AM J PHYSIOL-LUNG C, V280, pL1083
  30. Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460
  31. Szeredi L, 2006, VET PATHOL, V43, P755, DOI 10.1354/vp.43-5-755
  32. Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
  33. Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527
  34. Yersin C, 2000, T ROY SOC TROP MED H, V94, P71, DOI 10.1016/S0035-9203(00)90445-0
  35. Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8